company

Central South University

as of 2026-07-01
Monitor thisAsk about this
at a glance
32 trials sponsored · 34 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

34 assets
AripiprazoleHaloperidolMinocyclineOlanzapineQuetiapineRisperidoneActive iTBSAntipsychotic drugsAtorvastatinBaseline assessmentsCross-sectional assessmentDonepezilIntermittent theta burst stimulationIntermittent theta burst stimulation(iTBS)MetforminMetformin treatmentMood stabilizerParoxetinePsychosocial interventionRegular follow-up assessments without intervention.SulforaphaneTheta Burst StimulationTranscranial Magnetic StimulationVolunteer assessmentsaccelerated theta burst stimulationadjunctive groupantipsychotic medicationscTBS （the left cerebellum Crus II as the stimulation target）cTBS（the left temporoparietal cortex as the stimulation target）dietary fiberiTBSmetformin and lifestyle interventionrepetitive Transcranial Magnetic Stimulation (rTMS)temporal interference stimulation

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Haloperidol
small molecule
drug
Minocycline
small molecule
drug
Olanzapine
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Active iTBS
DEVICE
drug
Antipsychotic drugs
small molecule
drug